Vandana Sharma, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
University of Chicago Pritzker
Medical School
Stanford University
Residency
Stanford University
Fellowship
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Hospice & Palliative Medicine
American Board of Internal Medicine - Oncology
CA State Medical License: 2001 - 2017
American Board of Internal Medicine: Hospice and Palliative Medicine
American Board of Internal Medicine: Medical Oncology
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.
Vinayak, S.,Schwartz, E. J.,Jensen, K.,Lipson, J.,Alli, E.,McPherson, L.,Fernandez, A. M.,Sharma, V. B.,Staton, A.,Mills, M. A.,Schackmann, E. A.,Telli, M. L.,Kardashi...; Breast Cancer Res. Treat.. 2013 Oct 30.
See more >>Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.
Alli, E., Sharma, V.B., Sunderesakumar, P., Ford, J.M.; Cancer Res. 2009-04-15.
See more >>CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor.
Nettles, K.W., Gil, G., Nowak, J., Métivier, R., Sharma, V.B., Greene, G.L.; Mol Endocrinol. 2008 Feb.
See more >>American Society of Clinical Oncology